Altimmune, Inc.
ALT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61 | $183 | $49 | $37 |
| Short-Term Investments | $150 | $0 | $101 | $95 |
| Receivables | $0 | $1 | $2 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $3 | $2 |
| Total Curr. Assets | $217 | $188 | $155 | $137 |
| Property Plant & Equip (Net) | $2 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $2 | $2 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $218 | $190 | $157 | $139 |
| Liabilities | – | – | – | – |
| Payables | $5 | $1 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $8 | $8 | $10 |
| Total Curr. Liab. | $13 | $9 | $10 | $10 |
| LT Debt | $16 | $16 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $4 | $4 | $4 |
| Total NC Liab. | $20 | $20 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $2 |
| Total Liabilities | $33 | $29 | $15 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$622 | -$603 | -$581 | -$561 |
| AOCI | -$5 | -$5 | -$5 | -$5 |
| Other Equity | $813 | $770 | $728 | $690 |
| Total Equity | $186 | $161 | $142 | $124 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $218 | $190 | $157 | $139 |
| Net Debt | -$45 | -$167 | -$48 | -$35 |